PortfoliosLab logoPortfoliosLab logo
VNDA vs. ABAT
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

VNDA vs. ABAT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Vanda Pharmaceuticals Inc. (VNDA) and American Battery Technology Company Common Stock (ABAT). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, VNDA achieves a -31.97% return, which is significantly lower than ABAT's -12.28% return.


VNDA

1D
3.45%
1M
-3.07%
YTD
-31.97%
6M
-14.65%
1Y
33.04%
3Y*
-2.73%
5Y*
-20.51%
10Y*
-6.02%

ABAT

1D
-6.09%
1M
-9.29%
YTD
-12.28%
6M
-29.57%
1Y
130.71%
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

VNDA vs. ABAT - Yearly Performance Comparison


2026 (YTD)202520242023
VNDA
Vanda Pharmaceuticals Inc.
-31.97%84.13%13.51%-1.40%
ABAT
American Battery Technology Company Common Stock
-12.28%35.77%-47.55%-60.25%

Correlation

The correlation between VNDA and ABAT is 0.22, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.22

Correlation (All Time)
Calculated using the full available price history since Sep 21, 2023

0.14

Fundamentals

Market Cap

VNDA:

$356.76M

ABAT:

$386.34M

EPS

VNDA:

-$4.05

ABAT:

-$0.55

PS Ratio

VNDA:

1.63

ABAT:

20.92

PB Ratio

VNDA:

1.27

ABAT:

3.43

Total Revenue (TTM)

VNDA:

$217.78M

ABAT:

$16.28M

Gross Profit (TTM)

VNDA:

$154.79M

ABAT:

-$6.95M

EBITDA (TTM)

VNDA:

-$146.81M

ABAT:

-$62.40M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

VNDA vs. ABAT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

VNDA
VNDA Risk / Return Rank: 6060
Overall Rank
VNDA Sharpe Ratio Rank: 5656
Sharpe Ratio Rank
VNDA Sortino Ratio Rank: 6161
Sortino Ratio Rank
VNDA Omega Ratio Rank: 6363
Omega Ratio Rank
VNDA Calmar Ratio Rank: 6060
Calmar Ratio Rank
VNDA Martin Ratio Rank: 6060
Martin Ratio Rank

ABAT
ABAT Risk / Return Rank: 7272
Overall Rank
ABAT Sharpe Ratio Rank: 7272
Sharpe Ratio Rank
ABAT Sortino Ratio Rank: 7878
Sortino Ratio Rank
ABAT Omega Ratio Rank: 7676
Omega Ratio Rank
ABAT Calmar Ratio Rank: 7272
Calmar Ratio Rank
ABAT Martin Ratio Rank: 6464
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

VNDA vs. ABAT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Vanda Pharmaceuticals Inc. (VNDA) and American Battery Technology Company Common Stock (ABAT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


VNDAABATDifference
Sharpe ratioReturn per unit of total volatility

-0.59

Sortino ratioReturn per unit of downside risk

-0.86

Omega ratioGain probability vs. loss probability

1.18

1.26

-0.08

Calmar ratioReturn relative to maximum drawdown

0.83

1.69

-0.86

Martin ratioReturn relative to average drawdown

1.79

2.34

-0.55

VNDA vs. ABAT - Sharpe Ratio Comparison

The current VNDA Sharpe Ratio is 0.41, which is lower than the ABAT Sharpe Ratio of 1.00. The chart below compares the historical Sharpe Ratios of VNDA and ABAT, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

VNDA vs. ABAT - Drawdown Comparison

The maximum VNDA drawdown since its inception was -98.42%, which is greater than ABAT's maximum drawdown of -93.56%. Use the drawdown chart below to compare losses from any high point for VNDA and ABAT.


Loading charts...

Drawdown Indicators


VNDAABATDifference

Max Drawdown

Largest peak-to-trough decline

-98.42%

-93.56%

-4.86%

Max Drawdown (1Y)

Largest decline over 1 year

-40.06%

-77.85%

+37.79%

Max Drawdown (3Y)

Largest decline over 3 years

-49.25%

Max Drawdown (5Y)

Largest decline over 5 years

-84.29%

Max Drawdown (10Y)

Largest decline over 10 years

-89.26%

Current Drawdown

Current decline from peak

-81.05%

-75.17%

-5.88%

Average Drawdown

Average peak-to-trough decline

-65.11%

-77.62%

+12.51%

Ulcer Index

Depth and duration of drawdowns from previous peaks

18.50%

56.15%

-37.65%

Volatility

VNDA vs. ABAT - Volatility Comparison

The current volatility for Vanda Pharmaceuticals Inc. (VNDA) is 11.99%, while American Battery Technology Company Common Stock (ABAT) has a volatility of 40.44%. This indicates that VNDA experiences smaller price fluctuations and is considered to be less risky than ABAT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


VNDAABATDifference

Volatility (1M)

Calculated over the trailing 1-month period

11.99%

40.44%

-28.45%

Volatility (6M)

Calculated over the trailing 6-month period

64.42%

70.90%

-6.48%

Volatility (1Y)

Calculated over the trailing 1-year period

81.84%

132.17%

-50.33%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

60.53%

122.32%

-61.79%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

55.71%

122.32%

-66.61%

Dividends

VNDA vs. ABAT - Dividend Comparison

Neither VNDA nor ABAT has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

VNDA vs. ABAT - Financials Comparison

This section allows you to compare key financial metrics between Vanda Pharmaceuticals Inc. and American Battery Technology Company Common Stock. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0020.00M40.00M60.00M80.00M20222023202420252026
51.72M
7.81M
(VNDA) Total Revenue
(ABAT) Total Revenue
Values in USD except per share items

Frequently Asked Questions


VNDA and ABAT have a correlation of 0.22, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ABAT has higher volatility (40.44%) compared to VNDA (11.99%). In terms of maximum drawdown, VNDA dropped -98.42% vs ABAT's -93.56%.

ABAT currently has the higher Sharpe Ratio (1.00 vs 0.41), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for VNDA and ABAT

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer